Action EUCR EUCRATES BIOMEDICAL ACQUISITION CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Eucrates Biomedical Acquisition Corp.

Actions

EUCR

VGG3141W1068

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Eucrates Biomedical Acquisition Corp.(NasdaqCM:EUCR) dropped from NASDAQ Composite Index
EUCRATES BIOMEDICAL ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Eucrates Biomedical Acquisition Corp. Auditor Raises 'Going Concern' Doubt
Eucrates Biomedical Acquisition to Dissolve, Liquidate
Eucrates Biomedical Acquisition : Announces Liquidation - Form 8-K
EUCRATES BIOMEDICAL ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
Eucrates Biomedical Acquisition Corp. Announces Liquidation
Eucrates Biomedical Acquisition : New Financial Obligation - Form 8-K
EUCRATES BIOMEDICAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
EUCRATES BIOMEDICAL ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Eucrates Biomedical Acquisition Corp. announced that it has received $0.096 million in funding from Eucrates Llc
EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
EUCRATES BIOMEDICAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)
Eucrates Biomedical Acquisition Corp. announced that it has received $0.6 million in funding from Eucrates Llc
EUCRATES BIOMEDICAL ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure (form 8-K)
EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action EUCR
  4. Actualités Eucrates Biomedical Acquisition Corp.
  5. Autres langues